Researchers from Washington University School of Medicine in St. Louis have made significant strides in the treatment of amyotrophic lateral sclerosis (ALS), a debilitating neurological disease....
Cytokinetics has achieved a significant milestone with the approval of its first drug in the United States. On October 27, 2023, the U.S. Food and Drug...
Cytokinetics has achieved a significant milestone by securing its first drug approval from the U.S. Food and Drug Administration (FDA). The FDA granted clearance on January...
Cytokinetics has achieved a significant milestone with the approval of its first U.S. drug, Myqorzo, by the Food and Drug Administration (FDA). This approval, granted on...
The U.S. Food and Drug Administration (FDA) has issued a critical warning to major retailers, including Target and Walmart, after discovering that recalled ByHeart infant formula...
The future of the biopharmaceutical industry faces significant challenges, according to the former head of research and development at Pfizer. In a recent opinion piece, he...
Clearmind Medicine Inc. has successfully completed the enrollment of patients for the second cohort in its FDA-approved Phase I/IIa clinical trial assessing CMND-100, a proprietary oral...
U.S. health officials have expanded the approval of the libido-boosting pill, Addyi, to include women over the age of 65 who have undergone menopause. The announcement...
U.S. health officials have expanded the approval of the libido-boosting medication, Addyi, allowing women aged 65 and older who have gone through menopause to use the...
U.S. health officials have expanded the approval of the libido-enhancing pill, Addyi, to include women over the age of 65 who have gone through menopause. The...
